Atlas Trials

Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Clinical trial NCT00523042 · TERMINATED

Trial details

NCT number
NCT00523042
Sponsor
Novo Nordisk A/S
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Asthma
Start date
2007-08-30
Primary completion
2008-02-28
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.